Epidemiology, characteristics, and outcomes of patients with acute-on-chronic liver failure in Australia.

Background And Aim: Acute-on-chronic liver failure (ACLF) is distinct from acute decompensation (AD) of cirrhosis in its clinical presentation, pathophysiology, and prognosis. There are limited published Australian ACLF data.

Methods: We performed a single-center retrospective cohort study of all adults with cirrhosis admitted with a decompensating event to a liver transplantation (LT) centre between 2015 and 2020.

Impact of a satellite laboratory on turnaround times for the emergency department.

Background: Prolonged laboratory turnaround time (TAT) contributes to prolonged length of stay in emergency departments (EDs). The TAT of laboratory test results is a common key performance indicator by which clinicians and regulatory bodies evaluate laboratory performance. Establishing satellite laboratories in EDs staffed by laboratory technologists is one approach towards reducing TAT.

The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.

Recombinant human erythropoietin has proved to be effective to treat anemia of end-stage renal disease (ESRD). The aim of this study was to assess the efficacy and safety profile of Epotin, a rHuEPO produced in the Middle East. One hundred thirty patients with Hct View Article and Find Full Text PDF

Prognosis of malaria associated severe acute renal failure in children.

Between January and December 1996, we observed 64 children (mean age 8.3 years range 4.2 to 11.

Renal replacement therapy in yemen.

In this report we present the current status of dialysis and transplantation in Yemen. The reported incidence of end stage renal disease (ESRD) in one region of Yemen was estimated as 385 per million population (PMP) per year. The total population of Yemen is also estimated as 16,000,000.